Target intelligence / Profile preview

Globo H glycolipid antigen (Globo H)

Target
Globo H
Molecular classification
Glycolipid, Glycosphingolipid, Tumor-associated carbohydrate antigen (TACA)
01

Overview

Globo H is a hexasaccharide glycosphingolipid (Fucα1→2Galβ1→3GalNAcβ1→3Galα1→4Galβ1→4Glcβ1→Cer) that serves as a prominent tumor-associated carbohydrate antigen (TACA) (Huang et al., 2013, PNAS) [1]. It is overexpressed on the outer cell membrane of various epithelial cancers, including breast, prostate, lung, and ovarian cancers (Zhang et al., 1997, Cancer Res) [2]. In contrast, its expression on normal tissues is highly restricted, primarily found on the apical surface of epithelial cells in secretory organs such as the pancreas and salivary glands (OBI Pharma) [3]. This differential expression pattern makes it an attractive target for selective cancer therapies. In the context of malignancy, Globo H is thought to play roles in promoting tumor cell survival, migration, and angiogenesis (Chang et al., 2015) [4]. Therapeutic strategies targeting Globo H include active immunotherapy via carbohydrate-based vaccines, such as Adagloxad simolenin (OBI-822), which are designed to stimulate the patient's immune system to produce anti-Globo H antibodies (ClinicalTrials.gov) [5]. Additionally, passive immunotherapy approaches using humanized monoclonal antibodies (e.g., OBI-888) and antibody-drug conjugates (e.g., OBI-999) are being developed to directly target and kill Globo H-expressing cells (OBI Pharma) [3]. These interventions leverage mechanisms like antibody-dependent cellular cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC) to eliminate tumor cells. Clinical development of these agents focuses on patients whose tumors show high Globo H expression as determined by immunohistochemistry.

Other names
Globo H ceramideMBr1 antigenFucα1-2Galβ1-3GalNAcβ1-3Galα1-4Galβ1-4Glc-CerTumor-associated carbohydrate antigen Globo H
02

Mechanism of action

Induction of a humoral immune response through active vaccination, or direct tumor cell killing via antibody-dependent cellular cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), and targeted delivery of cytotoxic payloads using antibody-drug conjugates.

03

Biological functions

Cell-cell recognitionCell adhesionSignal transductionImmune evasion
04

Disease associations

Breast cancerProstate cancerLung cancerOvarian cancerPancreatic cancerGastric cancerEndometrial cancer
05

Safety considerations

Potential off-target binding to normal epithelial tissues in secretory organsLow natural immunogenicity of carbohydrate antigens requiring carrier proteinsImmune-related adverse events associated with vaccine-induced responses
06

Interacting drugs

Adagloxad simolenin (OBI-822)

3 more in the full profile.

07

Biomarkers

Globo H expression (via Immunohistochemistry)

Beyond the preview

Go deeper on Globo H glycolipid antigen (Globo H).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Globo H glycolipid antigen (Globo H).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call